Volume has been low on the decline and this morning it's weak on the rise. We need to see some good 2Q sales from Kadcyla to help drive new investors into the stock. IMGN's efforts to attract new investors through public appearances does not seem to be effective. Other than John Lambert, I am not impressed with IMGN execs. Listen to the ECYT cc replay from Jeffries, their CFO blows Junius away IMO. Here we go, rally is already failing in the time to took me to write this! Back to the day job, no retirement today!
I really don't think this is as much a problem with IMGN as it is with the market in general. The general market has not had 3 days of pull-back in 106 sessions, and a correction is due. The previous record was 53 sessions. It's been a good ride and I expect this is a temporary setback and it is close to being a time to buy. I truly believe the technology behind this company is just getting going, and growth is on it's way soon.
Most of my portfolio is down. I would say given ImmunoGen is staying in the 16's is pretty good sign of the health of this stock. In previous years this stock would drop like a stone during down times in the market.